Altamira Therapeutics Ltd. Shortterm Employee Benefits Expense
Altamira Therapeutics Ltd. (CYTOF) reported Shortterm Employee Benefits Expense of CHF 150.44 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-05-16.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ShorttermEmployeeBenefitsExpense · last filed 2023-05-16
| Period end | Shortterm Employee Benefits Expense 12 month |
|---|---|
| 2022-12-31 | 150.44K CHF 20-F · filed 2023-05-16 |
| 2021-12-31 | 89.24K CHF 20-F · filed 2023-05-16 |